- To meet 40% of power demand from renewable energy by FY 2026-27 and 100% by FY 2032-33.
- Carbon neutral in direct operations (Scope 1 and2 emissions) by FY 2032-33.
- Zero Liquid discharge (ZLD) for all plant location.
- To achieve Zero waste to Landfill by FY 2032-33.
- To achieve water positivity by FY 2032-33.
- Enhance women representation in workfence (permanent) to 15% by FY 26-27 and across cadres to 25% by FY 2032-33.
- 25 average learning hours per employee by FY 2026-27
- To continue Zero Fatality at all plants and locations.
- Meet the highest standards on compliance and ethics backed by robust corporate governance.
- To continuously produce quality and affordable products for patients globally.
- Enhance our disclosures to reach top quartile by FY 2026-27 (Enhanced disclosures with the release of several policies on our website. Comprehensive BRSR, Sustainability Reporting, independent assurance and enhanced ESG disclosures.)